Pharmaceutical Investments Before and After TRIPS

Kyle, Margaret and McGahan, Anita M. (2012) Pharmaceutical Investments Before and After TRIPS. Review of Economics and Statistics, 94 (4). pp. 1157-1172.

Full text not available from this repository.
Official URL: http://tse-fr.eu/pub/24360

Abstract

The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the World Trade Organization, has increased levels of patent protection around the world. Using variation across countries in the timing of patent laws and the severity of disease, we test the hypothesis that increased patent protection results in greater drug development effort. We find that patent protection in wealthy countries is associated with increases in research and development (R&D) effort. However, the introduction of patents in developing countries has not been followed by greater R&D investment in the diseases that are most prevalent there.

Item Type: Article
Language: English
Date: November 2012
Refereed: Yes
JEL codes: F13 - Commercial Policy; Protection; Promotion; Trade Negotiations; International Trade Organizations
I18 - Government Policy; Regulation; Public Health
L65 - Chemicals; Rubber; Drugs; Biotechnology
O32 - Management of Technological Innovation and R&D
O34 - Intellectual Property Rights - National and International Issues
Subjects: B- ECONOMIE ET FINANCE
Divisions: TSE-R (Toulouse)
Site: UT1
Date Deposited: 09 Jul 2014 17:19
Last Modified: 07 Mar 2018 13:22
OAI ID: oai:tse-fr.eu:24360
URI: http://publications.ut-capitole.fr/id/eprint/15130

Actions (login required)

View Item View Item